Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation
- PMID: 26991618
- PMCID: PMC4800821
- DOI: 10.1213/ANE.0000000000001163
Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation
Abstract
Background: Severe primary graft dysfunction (PGD) is a major cause of early morbidity and mortality in patients after lung transplantation. The etiology and pathophysiology of PGD is not fully characterized and whether intraoperative fluid administration increases the risk for PGD remains unclear from previous studies. Therefore, we tested the hypothesis that increased total intraoperative fluid volume during lung transplantation is associated with the development of grade-3 PGD.
Methods: This retrospective cohort analysis included patients who had lung transplantation at the Cleveland Clinic between January 2009 and June 2013. We used multivariable logistic regression with adjustment for donor, recipient, and perioperative confounding factors to examine the association between total intraoperative fluid administration and development of grade-3 PGD in the initial 72 postoperative hours. Secondary outcomes included time to initial extubation and intensive care unit length of stay.
Results: Grade-3 PGD occurred in 123 of 494 patients (25%) who had lung transplantation. Patients with grade-3 PGD received a larger volume of intraoperative fluid (median 5.0 [3.8, 7.5] L) than those without grade-3 PGD (3.9 [2.8, 5.2] L). Each intraoperative liter of fluid increased the odds of grade-3 PGD by approximately 22% (adjusted odds ratio, 1.22; 95% confidence interval [CI], 1.12-1.34; P <0.001). The volume of transfused red blood cell concentrate was associated with grade-3 PGD (1.1 [0.0, 1.8] L for PGD-3 vs 0.4 [0.0, 1.1 for nongrade-3 PGD] L; adjusted odds ratio, 1.7; 95% CI, 1.08-2.7; P = 0.002). Increased fluid administration was associated with longer intensive care unit stay (adjusted hazard ratio, 0.92; 97.5% CI, 0.88-0.97; P < 0.001) but not with time to initial tracheal extubation (hazard ratio, 0.97; 97.5% CI, 0.93-1.02; P = 0.17).
Conclusions: Increased intraoperative fluid volume is associated with the most severe form of PGD after lung transplant surgery. Limiting fluid administration may reduce the risk for development of grade-3 PGD and thus improve early postoperative morbidity and mortality after lung transplantation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Comment in
-
Lung Transplantation Is Much More Than Lungs and Fluids.Anesth Analg. 2016 Sep;123(3):794-5. doi: 10.1213/ANE.0000000000001375. Anesth Analg. 2016. PMID: 27258071 No abstract available.
-
In Response.Anesth Analg. 2016 Sep;123(3):795-6. doi: 10.1213/ANE.0000000000001374. Anesth Analg. 2016. PMID: 27537765 Free PMC article. No abstract available.
Similar articles
-
Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):314-20. doi: 10.1093/icvts/ivv357. Epub 2015 Dec 23. Interact Cardiovasc Thorac Surg. 2016. PMID: 26705301 Free PMC article.
-
Perioperative statin use is associated with decreased incidence of primary graft dysfunction after lung transplantation.J Heart Lung Transplant. 2017 Sep;36(9):948-956. doi: 10.1016/j.healun.2017.05.007. Epub 2017 May 6. J Heart Lung Transplant. 2017. PMID: 28552627
-
Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.Transplant Proc. 2012 Oct;44(8):2462-8. doi: 10.1016/j.transproceed.2012.07.134. Transplant Proc. 2012. PMID: 23026621
-
Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system.J Heart Lung Transplant. 2007 May;26(5):431-6. doi: 10.1016/j.healun.2007.01.029. Epub 2007 Mar 21. J Heart Lung Transplant. 2007. PMID: 17449410 Review.
-
Post Lung Transplant Primary Graft Dysfunction.Semin Thorac Cardiovasc Surg. 2025 Summer;37(2):192-198.e1. doi: 10.1053/j.semtcvs.2025.04.001. Epub 2025 Apr 21. Semin Thorac Cardiovasc Surg. 2025. PMID: 40268260 Review.
Cited by
-
Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases.Curr Drug Metab. 2022;23(11):882-896. doi: 10.2174/1389200223666220803103039. Curr Drug Metab. 2022. PMID: 35927812
-
Fluid management during pediatric lung transplantation: a single-center experience.Transl Pediatr. 2025 May 30;14(5):881-892. doi: 10.21037/tp-2024-619. Epub 2025 May 27. Transl Pediatr. 2025. PMID: 40519743 Free PMC article.
-
Current Perspectives and Future Directions in Lung Transplantation.Life (Basel). 2023 Jun 23;13(7):1432. doi: 10.3390/life13071432. Life (Basel). 2023. PMID: 37511807 Free PMC article.
-
Effects of intraoperative fluid therapy on intensive care process, morbidity, and mortality after lung transplantation.Turk Gogus Kalp Damar Cerrahisi Derg. 2023 Jan 30;31(1):78-86. doi: 10.5606/tgkdc.dergisi.2023.22917. eCollection 2023 Jan. Turk Gogus Kalp Damar Cerrahisi Derg. 2023. PMID: 36926153 Free PMC article.
-
Perioperative fluid management for lung transplantation is challenging.Heliyon. 2023 Mar 21;9(4):e14704. doi: 10.1016/j.heliyon.2023.e14704. eCollection 2023 Apr. Heliyon. 2023. PMID: 37035359 Free PMC article. Review.
References
-
- Christie J, Sager J, Kimmel S, Vivek A, Gaughan C, Blumental N, Kotloff R. Impact of primary graft failure on outcomes following lung transplantation. Chest. 2005;127:161–165. - PubMed
-
- Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction: Part II Definition. J Heart Lung Transplant. 2005;24:1454–1459. - PubMed
-
- Prekker M, Nath D, Walker A, Johnson A, Hertz M, Herrington C, Radosevich D, Dahlberg P. Validation of the Proposed International Society for Heart and Lung Transplantation Grading System for Primary Graft Dysfunction After Lung Transplantation. The J Heart and Lung Transplant. 2006;25(4):371–78. - PubMed
-
- Christie J, Bellamy S, Ware L, Lederer D, Hadjiliadis D, Lee J, Robinson N, Localio A, Wille K, Lama V, Palmer S, Orens J, Weinacher A, Crespo M, Demissie E, Kimmel S, Kawut S. Construct validity of the primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2010;29:1231–9. - PMC - PubMed
-
- Whitson B, Prekker M, Herrington C, Whelan T, Radosevich D, Hertz M, Dahlberg P. Primary graft dysfunction and long-term pulmonary function after lung transplantation. J Heart Lung Transplant. 2007;26:1004–11. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous